Biocryst Pharmaceuticals Inc. (BCRX) Stock Experiences 13.41% Monthly Change
In the past week, BCRX stock has gone up by 3.85%, with a monthly gain of 13.41% and a quarterly surge of 17.72%. The volatility
In the past week, BCRX stock has gone up by 3.85%, with a monthly gain of 13.41% and a quarterly surge of 17.72%. The volatility
The stock of Biocryst Pharmaceuticals Inc. (BCRX) has seen a 6.28% increase in the past week, with a 2.05% gain in the past month, and
The stock of Biocryst Pharmaceuticals Inc. (BCRX) has seen a 4.41% increase in the past week, with a -4.42% drop in the past month, and
Moreover, the 36-month beta value for BCRX is 1.90. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 2
BioCryst Pharmaceuticals, Inc. (BCRX), a biotechnology company, is trading at $11.64 in the current market after plunging 34.90% since the start of the trading session.
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.